Court grants order to resolve Amgen v FDA paediatric dispute

06-06-2017

Court grants order to resolve Amgen v FDA paediatric dispute

tomloel / iStockphoto.com

A district court has granted a stipulated order to the US Food and Drug Administration (FDA) and Amgen, after they jointly asked the court to end a case centring on paediatric exclusivity for Sensipar (cinacalcet).


Amgen, FDA, Sensipar, paediatric exclusivity, patent, TRO,

LSIPR